Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.
about
HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanismsAbsence of ghrelin protects against early-onset obesityObesity: Current and potential pharmacotherapeutics and targets.Neuroendocrine control of GH release during acute aerobic exercise.Shrinking due to corpulence? BMI in childhood predicts subsequent linear growth among US children and youth, 1963-1970.Effects of exercise training intensity on nocturnal growth hormone secretion in obese adults with the metabolic syndrome.Motivations and methods for analyzing pulsatile hormone secretionEffects of continuous versus intermittent exercise, obesity, and gender on growth hormone secretion.Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applicationsReview: Ageing and hormones.Correlation of Circulating Acid-Labile Subunit Levels with Insulin Sensitivity and Serum LDL Cholesterol in Patients with Type 2 Diabetes: Findings from a Prospective Study with RosiglitazoneThree-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity.Increased neck soft tissue mass and worsening of obstructive sleep apnea after growth hormone treatment in men with abdominal obesityRelationship of peak growth hormone to cardiovascular parameters, waist circumference, lipids and glucose in HIV-infected patients and healthy adults.Update on endocrine disturbances in anorexia nervosa.Growth hormone, IGF-I and insulin and their abuse in sport.Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses.Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite.Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout miceEffects of growth hormone administration in human obesity.Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies.GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90Mechanisms underlying the neuroendocrine response to physical exercise.The clinical biochemistry of obesity.Hypopituitarism in Traumatic Brain Injury-A Critical Note.Sex Differences in Somatotrope Dependency on Leptin Receptors in Young Mice: Ablation of LEPR Causes Severe Growth Hormone Deficiency and Abdominal Obesity in Males.Low Insulin-Like Growth Factor-1 Level in Obesity Nephropathy: A New Risk Factor?Cardiovascular risk in aging and obesity: is there a role for GH.Effects of gender, body weight, and blood glucose dynamics on the growth hormone response to the glucagon stimulation test in patients with pituitary disease.Differences in the GH-IGF-I axis in children of different weight and fitness status.Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesitySevere growth hormone deficiency is rare in surgically-cured acromegalics.Impaired IGF1-GH axis and new therapeutic options in Alström Syndrome patients: a case series.Body composition in Egyptian Turner syndrome girls.Influence of body mass index on the growth hormone response to provocative testing in short children without growth hormone deficiency.Influence of Behavioral and Environmental Factors on the Development of Obesity in Three-year-old Children -A Case-Control Study Based on Toyama Study-Growth and puberty in children with HIV infection.Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: an update.The metabolic effects of growth hormone in adipose tissue.
P2860
Q21245028-DB7E2066-5CEA-42DB-B6EF-B45F782AE390Q28593792-36EFD909-DAA1-4850-AF40-70D9D3AB947CQ30243992-28B89382-59BA-4300-AC09-356F08DBD1FEQ30312103-E84DA0BB-8C74-41A5-8DFE-85F4EB5B86ADQ30319477-0569069B-B4D1-4D74-9BCB-8096A32491E8Q30435986-6D5F45DA-CCDA-44E2-88B9-CAAC5CD67A3FQ30437731-10E70C54-1416-4812-A5EF-BEF24D06720BQ30437776-84F12521-6F3E-4284-BF3A-31376C6E80EAQ30449301-D2E2EDD7-9903-42C0-86D2-3AC8CFA9AAEFQ33593233-C4F5D5C4-D07D-42F9-8822-4DB825073140Q33748524-CEB8F33B-08A6-4F2C-8C42-CD47C45E000DQ33858074-3C485DD4-127B-42B9-9E09-ACE18C34D40EQ33903274-07B4EEB7-F109-43A6-AA9B-6A09CB8EC261Q33926905-35DD3DB2-4FBF-4FF4-B67A-109CD1BC5443Q33950114-BC8E7C94-5D16-4060-8730-70575DBD6320Q34010760-5882E2BB-B67D-487F-8EFB-CE6AF573AAFAQ34170486-72AAE9D7-C640-48E7-8792-26008A239C7AQ34446998-79637CD8-3C67-40B5-BA75-A72BF07D683EQ34730646-C85A402D-3F19-4F7D-98B7-F5CED15DCA99Q35064726-EE64E4FD-9E1C-4126-87BB-4B073B6D19C6Q35072510-6BEE754C-1B05-49BC-85F0-8720D034151FQ35103887-0A22C091-56E9-4292-96C1-196A13FC2D5CQ35667568-6EF80CFB-58C9-4E18-A36C-BD9C3DDEB219Q35819237-DC97340A-EB7F-4252-BB4E-220386557847Q35902224-D9BCE958-7FD7-47F3-A3A2-D3544B7EE4C5Q35970845-0050544F-9991-4CE9-BFFE-460FF3EC01BEQ36006630-67900579-FCB8-4765-80FF-5BB71A27C269Q36309188-6F67886E-D7A9-4B03-AC40-06E4E85E300CQ36473060-4E607572-01F2-476B-8A09-807EF6988C57Q36593281-14BB9C71-A80C-4AB7-9FE0-92056AC084B8Q36755284-9342076E-D8DD-4AA7-8D85-1F8864BA143AQ36890621-D3EF7716-FBF0-40F7-B22B-768354B8CBB3Q37061298-A47DB3BC-9F98-41B1-AEDF-BCC6476D2F3CQ37111966-79A6EC6D-1BDD-4210-A80F-F85ED821B676Q37136049-1362DD14-B136-409C-84FC-C4B0EAB2B7B1Q37147355-F3DC34D1-E2D6-4F4A-AF18-4BB528FCC8C5Q37296205-287B9460-DC70-420C-B629-6135482C7E13Q37428510-188657CD-0BD1-4C52-B98A-1332750ACDEBQ37737002-DE5B6F97-4872-404E-84EC-136EB2CCDCD5Q38083594-1B7C6660-C50C-4610-BB09-ECBE9008F794
P2860
Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Dual defects in pulsatile grow ...... matotropism of obesity in man.
@ast
Dual defects in pulsatile grow ...... matotropism of obesity in man.
@en
type
label
Dual defects in pulsatile grow ...... matotropism of obesity in man.
@ast
Dual defects in pulsatile grow ...... matotropism of obesity in man.
@en
prefLabel
Dual defects in pulsatile grow ...... matotropism of obesity in man.
@ast
Dual defects in pulsatile grow ...... matotropism of obesity in man.
@en
P2093
P356
P1476
Dual defects in pulsatile grow ...... matotropism of obesity in man.
@en
P2093
P356
10.1210/JCEM-72-1-51
P407
P577
1991-01-01T00:00:00Z